if one looks into Biontech's financial statements carefully
if one looks into Biontech's financial statements carefully, it's deferred revenue liabilities are particularly small in comparison to Moderna's. More precisely, it amounts to 0.24 bln vs 7,3 bln. This line shows the money's received from contacts for which no delivery has been made yet. If both entities follow the same accounting standards (maybe Moderna is following GAAP Vs IFRS), it demonstrates that Moderna is vastly behind in its contractual obligations by an unreasonable factor and Bntx is serving it's contractual obligations at a normal pace. If this doesn't show credibility what does$BioNTech SE(BNTX)$
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
